AstraZeneca Kidrey Drug Trial Successful By Investing.com
© Reuters.
Investing.com — Here is a roundup of regulatory releases from the London Stock Exchange on Friday, 8th November. Please refresh for updates.
- Pharma group AstraZeneca (LON:) reported successful Phase III trials for its roxadustat drug, used to treat anemia in patients suffering from chronic kidney disease.
- It said it expects to make a regulatory submission for the drug to be approved in the U.S. by year-end.
Share with your friends!
